tyrosine and Pleural Effusion, Malignant

tyrosine has been researched along with Pleural Effusion, Malignant in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gabius, HJ; Lala, PK; Lan, Y; Timoshenko, AV	1

Other Studies

1 other study(ies) available for tyrosine and Pleural Effusion, Malignant

Article	Year
Immunotherapy of C3H/HeJ mammary adenocarcinoma with interleukin-2, mistletoe lectin or their combination. effects on tumour growth, capillary leakage and nitric oxide (NO) production. European journal of cancer (Oxford, England : 1990), 2001, Volume: 37, Issue:15 Topics: Adenocarcinoma; Adjuvants, Immunologic; Animals; Capillary Permeability; Female; Interleukin-2; Kidney; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Nitric Oxide; Plant Preparations; Plant Proteins; Pleural Effusion, Malignant; Recombinant Proteins; Ribosome Inactivating Proteins, Type 2; Toxins, Biological; Tumor Cells, Cultured; Tyrosine	2001

Article

Year

Immunotherapy of C3H/HeJ mammary adenocarcinoma with interleukin-2, mistletoe lectin or their combination. effects on tumour growth, capillary leakage and nitric oxide (NO) production.

European journal of cancer (Oxford, England : 1990), 2001, Volume: 37, Issue:15

Topics: Adenocarcinoma; Adjuvants, Immunologic; Animals; Capillary Permeability; Female; Interleukin-2; Kidney; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Nitric Oxide; Plant Preparations; Plant Proteins; Pleural Effusion, Malignant; Recombinant Proteins; Ribosome Inactivating Proteins, Type 2; Toxins, Biological; Tumor Cells, Cultured; Tyrosine

2001